Enorama Pharma AB (publ) (STO: ERMA)
Sweden
· Delayed Price · Currency is SEK
4.090
-0.140 (-3.31%)
Nov 20, 2024, 4:39 PM CET
Enorama Pharma AB Balance Sheet
Financials in millions SEK. Fiscal year is January - December.
Millions SEK. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | 2018 - 2014 |
---|---|---|---|---|---|---|---|
Period Ending | Sep '24 Sep 30, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | Dec '19 Dec 31, 2019 | 2018 - 2014 |
Cash & Equivalents | 9.62 | 6.15 | 4.14 | 12.2 | 4.73 | 14.61 | Upgrade
|
Cash & Short-Term Investments | 9.62 | 6.15 | 4.14 | 12.2 | 4.73 | 14.61 | Upgrade
|
Cash Growth | 42.66% | 48.66% | -66.07% | 157.71% | -67.59% | -11.11% | Upgrade
|
Accounts Receivable | 2.39 | 0.02 | 1.95 | 7.06 | 5.07 | 1.21 | Upgrade
|
Other Receivables | 0.66 | 2.03 | 2.37 | 1.45 | 1.12 | 0.73 | Upgrade
|
Receivables | 3.06 | 2.05 | 4.32 | 8.5 | 6.18 | 1.94 | Upgrade
|
Inventory | 8.94 | 4.29 | 2.84 | 1.24 | 1.72 | - | Upgrade
|
Prepaid Expenses | 1.11 | 0.47 | 0.45 | 0.47 | 0.19 | 1.47 | Upgrade
|
Total Current Assets | 22.73 | 12.96 | 11.75 | 22.41 | 12.82 | 18.02 | Upgrade
|
Property, Plant & Equipment | 0.41 | 0.86 | 1.54 | 2.22 | 2.83 | 1.63 | Upgrade
|
Long-Term Deferred Charges | 18.41 | 20.56 | 23.43 | 26.3 | 25.26 | 22.93 | Upgrade
|
Other Long-Term Assets | - | - | 12 | - | - | - | Upgrade
|
Total Assets | 41.54 | 34.39 | 48.72 | 50.93 | 40.91 | 42.58 | Upgrade
|
Accounts Payable | 0.99 | 3.72 | 5.35 | 2.18 | 1.92 | 3.67 | Upgrade
|
Accrued Expenses | 1.66 | 4.02 | 2.04 | 2.24 | 1.75 | 1.81 | Upgrade
|
Current Portion of Long-Term Debt | 0.33 | 0.13 | 1.46 | 2.09 | 1.94 | - | Upgrade
|
Current Income Taxes Payable | 0.15 | 0.29 | 0.43 | 0.39 | 0.33 | 0.28 | Upgrade
|
Other Current Liabilities | 4.69 | 2.06 | 3.14 | 4.79 | 12.68 | 4.64 | Upgrade
|
Total Current Liabilities | 7.83 | 10.22 | 12.43 | 11.68 | 18.61 | 10.41 | Upgrade
|
Long-Term Debt | - | 0.3 | 0.45 | 1.7 | 3.77 | - | Upgrade
|
Other Long-Term Liabilities | - | 4.33 | 4.33 | 16.2 | 16.75 | 25 | Upgrade
|
Total Liabilities | 7.83 | 14.85 | 17.2 | 29.58 | 39.13 | 35.41 | Upgrade
|
Common Stock | 9.45 | 6.39 | 1.46 | 1.2 | 0.92 | 0.86 | Upgrade
|
Additional Paid-In Capital | 237.99 | 205.32 | 176.55 | 126.45 | 79.3 | 13.92 | Upgrade
|
Retained Earnings | -213.72 | -192.18 | -149.07 | -106.29 | -78.44 | -7.61 | Upgrade
|
Comprehensive Income & Other | - | - | 2.58 | - | - | - | Upgrade
|
Shareholders' Equity | 33.72 | 19.54 | 31.52 | 21.35 | 1.78 | 7.18 | Upgrade
|
Total Liabilities & Equity | 41.54 | 34.39 | 48.72 | 50.93 | 40.91 | 42.58 | Upgrade
|
Total Debt | 0.33 | 0.44 | 1.91 | 3.79 | 5.71 | - | Upgrade
|
Net Cash (Debt) | 9.28 | 5.72 | 2.23 | 8.41 | -0.98 | 14.61 | Upgrade
|
Net Cash Growth | 47.88% | 156.37% | -73.49% | - | - | -1.85% | Upgrade
|
Net Cash Per Share | - | 0.21 | 0.28 | 1.36 | -0.18 | 2.72 | Upgrade
|
Filing Date Shares Outstanding | - | 40.93 | 25.86 | 7.69 | 5.91 | 5.53 | Upgrade
|
Total Common Shares Outstanding | - | 40.93 | 9.35 | 7.69 | 5.91 | 5.53 | Upgrade
|
Working Capital | 14.9 | 2.75 | -0.67 | 10.73 | -5.79 | 7.61 | Upgrade
|
Book Value Per Share | - | 0.48 | 3.37 | 2.78 | 0.30 | 1.30 | Upgrade
|
Tangible Book Value | 33.72 | 19.54 | 31.52 | 21.35 | 1.78 | 7.18 | Upgrade
|
Tangible Book Value Per Share | - | 0.48 | 3.37 | 2.78 | 0.30 | 1.30 | Upgrade
|
Machinery | - | 3.37 | 3.37 | 3.37 | 3.19 | 0.88 | Upgrade
|
Construction In Progress | - | - | - | - | 0.12 | 0.92 | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.